Peyton Group | Control Group | Between Subject Factor Intervention | Between Subject Factor Gender | |||||
---|---|---|---|---|---|---|---|---|
Women | Men | Women | Men | F(1,83) | p | F(1,83) | p | |
OSPE total score | 57 ± 12.3 | 61.9 ± 12.4 | 54.7 ± 13.7 | 45.2 ± 20.3 | 8.9 | 0.004* | 0.5 | 0.5 |
OSPE diagnostic part | 22.5 ± 7.1 | 24.8 ± 5.6 | 24.3 ± 8.4 | 21.1 ± 9.5 | 0.3 | 0.6 | 0.1 | 0.8 |
OSPE therapeutic part | 34.5 ± 8.1 | 36.6 ± 9.8 | 30.4 ± 8.1 | 24.1 ± 11.7 | 16.4 | <0.001* | 1.1 | 0.3 |
Cervical spine Diagnosis | 5.5 ± 1.4 | 5.9 ± 1.6 | 5.8 ± 1.9 | 6.2 ± 1.9 | 0.6 | 0.5 | 0.9 | 0.3 |
Cervical spine Therapy | 5.4 ± 4.1 | 6.3 ± 4.2 | 5.4 ± 2.9 | 4.7 ± 3.6 | 0.7 | 0.4 | 0.02 | 0.9 |
Thoracic spine Diagnosis | 5.1 ± 1.6 | 5.8 ± 1.2 | 5.5 ± 1.6 | 5.2 ± 2.1 | 0.1 | 0.8 | 0.4 | 0.5 |
Thoracic spine Therapy | 8.6 ± 2.3 | 9.8 ± 2.1 | 8.2 ± 2.4 | 7.2 ± 3.3 | 7.4 | 0.008* | 0.02 | 0.9 |
Lumbar spine Diagnosis | 3 ± 2.4 | 4.3 ± 2 | 3.4 ± 2.7 | 3.3 ± 2.7 | 0.3 | 0.6 | 1.2 | 0.3 |
Lumbar spine Therapy | 10.3 ± 3.7 | 10.7 ± 3.9 | 8.7 ± 3.4 | 6.6 ± 4.9 | 11.3 | 0.001* | 0.9 | 0.3 |
Sacroiliac joint Diagnosis | 8.9 ± 3.9 | 8.9 ± 3.4 | 9.6 ± 4.4 | 6.4 ± 4.4 | 0.9 | 0.3 | 3.1 | 0.08 |
Sacroiliac joint Therapy | 10.2 ± 1.5 | 9.8 ± 3.1 | 8.2 ± 2.7 | 5.6 ± 4.5 | 24.8 | <0.001* | 5.3 | 0.02* |
Multiple choice exam | 6.8 ± 1.6 | 7.4 ± 1.5 | 6.8 ± 2.1 | 5.9 ± 1.8 | 3.7 | 0.06 | 0.2 | 0.7 |